Journal for ImmunoTherapy of Cancer (Nov 2020)

722 Inhibition of integrin avß8-Mediated TGF-ß activation with C6D4 provides improved potency and selectivity vs general TGF-ß inhibitors for cancer immunotherapy

  • Robert Seed,
  • Stephen Nishimura

DOI
https://doi.org/10.1136/jitc-2020-sitc2020.0722
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.